Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.01.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Sang-Soo Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, CHA University, Gyeonggi-Do, 13488, Republic of Korea. Hauptthemen laut MEDLINE: alpha-Synuclein, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Ministry of Education, National Research Foundation of Korea.
Abstract (Originalsprache)
α-synuclein is one of the proteins involved in degenerative neuronal diseases such as Parkinson's disease (PD) or Lewy body dementia (LBD). The pathogenesis is imparted by the abnormal accumulation of α-synuclein resulting in the formation of a Lewy body (LB) and exerting neurotoxicity via an unknown mechanism. Regulation of α-synuclein is achieved by the ubiquitin-proteasome system (UPS), which influences protein homeostasis via inducing proteasome-dependent degradation by attaching a small molecule (ubiquitin) to the substrate. Deubiquitinating enzymes (DUBs) control the UPS by cleaving the peptide or isopeptide bond between ubiquitin and its substrate proteins. In a previous study, we found that YOD1 deubiquitinates and regulates the cellular function of neural precursor cell expressed developmentally down-regulated protein 4 (NEDD4), an E3 ligase that induces α-synuclein degradation. We hypothesized that YOD1 acts as a DUB involved in a modulated pathway of α-synuclein. In the current study, we found that YOD1 directly interacts with α-synuclein and deubiquitinates K6-, K11-, K29-, K33-, and K63-linked polyubiquitin chains on α-synuclein. Furthermore, YOD1 destabilizes α-synuclein protein stability by upregulating NEDD4. Collectively, this suggests the possibility that YOD1 is potentially a new regulator in the NEDD4-α-synuclein pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, CHA University, Gyeonggi-Do, 13488, Republic of Korea.
- Department of Biomedical Science, CHA University, Gyeonggi-Do, 13488, Republic of Korea. Electronic address: baek@cha.ac.kr.
Förderung
- Ministry of Education
- National Research Foundation of Korea
Zitieren
APA
Park, S. S., Do, H. A., Park, H. B., Choi, H. S., & Baek, K. H. (2023). Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.01.030
Vancouver
Park SS, Do HA, Park HB, Choi HS, Baek KH. Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.01.030
BibTeX
@article{Park2023,
author = {Park, Sang-Soo and Do, Hyeon-Ah and Park, Hong-Beom and Choi, Hae-Seul and Baek, Kwang-Hyun},
title = {Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.01.030}
}
EUVIMED